Novasep was a prominent international provider of integrated services and technologies for the life sciences industry, with a strong focus on purification-based manufacturing solutions. Their core offerings encompassed process development services, innovative purification equipment (especially chromatography systems), and contract development and manufacturing organization (CDMO) services for active pharmaceutical ingredients (APIs) and biopharmaceuticals. Novasep specialized in challenging molecules and offered solutions for viral vectors, monoclonal antibodies, and other complex biologics. In February 2022, Sartorius Stedim Biotech completed the acquisition of Novasep's life science business (primarily its chromatography division), aiming to significantly enhance Sartorius's portfolio in downstream bioprocessing and continuous manufacturing technologies. Novasep's capabilities and assets are now part of Sartorius's broader offerings.
Served as the central hub for corporate strategy, global operations management, R&D direction, financial oversight, and administrative functions before its acquisition by Sartorius.
Located within the Parc Technologique de Lyon, fostering collaboration and innovation by proximity to other tech and life science entities. Modern office facilities geared towards a dynamic work environment.
Characterized by a strong emphasis on scientific innovation, engineering excellence, customer-centricity, and problem-solving for complex purification challenges in the pharmaceutical and biopharmaceutical sectors.
The Lyon headquarters was strategically pivotal for Novasep, leveraging its location in a key European life sciences cluster to attract talent, forge partnerships, and access global markets.
Prior to its acquisition by Sartorius, Novasep maintained a significant global presence with multiple manufacturing sites, R&D centers, and commercial offices across Europe (notably France, Germany, Belgium), North America (USA), and Asia (including China and India). This network supported its comprehensive offerings in process development, supply of purification equipment, and CDMO services for global chemical and biopharmaceutical clients. Its international footprint enabled tailored solutions and strong customer relationships worldwide.
Parc Technologique de Lyon, 81 Boulevard Stalingrad
Villeurbanne (Lyon)
Auvergne-Rhône-Alpes
France
Address: Boulevard de la Moselle, BP 50, 54340 Pompey, France
Served as a primary European production and innovation hub, particularly for large-scale chromatography and synthesis projects.
Address: CHEMPARK, Building B107, Kaiser-Wilhelm-Allee, 51368 Leverkusen, Germany
Strategic production and R&D site within a major chemical park, leveraging synergies for raw materials and expertise in Central Europe.
Address: Building 5, No. 258, Wenjing Road, Minhang District, Shanghai, China
Hub for accessing and serving the rapidly expanding APAC life sciences sector, offering localized solutions.
Address: 23 Creek Circle, Boothwyn, PA 19061, USA
Primary base for Novasep's operations, sales, and technical support in the Americas market.
Address: Avenue F.Joliot Curie, BP 33, 64150 Mourenx, France
Important production facility for specialized chemical synthesis and handling of hazardous materials for the pharmaceutical industry.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Novasep' leadership includes:
Novasep has been backed by several prominent investors over the years, including:
The most significant 'executive event' for Novasep was its acquisition by Sartorius, finalized in February 2022. This led to the integration of Novasep's leadership and operations into Sartorius. Consequently, Novasep-specific executive roles largely ceased to exist in their prior form, with personnel either transitioning to new roles within Sartorius, taking on different responsibilities, or departing. There have been no 'Novasep' specific executive hires as an independent entity in the last 12 months.
Discover the tools Novasep uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Historically, Novasep commonly utilized email formats based on employee names, primarily [first_initial][last_name]@novasep.com (e.g., jdoe@novasep.com) or sometimes [first_name].[last_name]@novasep.com. It's important to note that since the acquisition by Sartorius, these Novasep-specific email addresses are likely inactive or rerouted. Current contacts would use Sartorius email domains (e.g., @sartorius.com).
[first_initial][last_name]@novasep.com or [first_name].[last_name]@novasep.com
Format
jdoe@novasep.com or jane.doe@novasep.com
Example
5%
Success rate
Sartorius Official Website • February 7, 2022
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, announced it has closed the acquisition of the life science business of Novasep. The transaction was completed on February 7, 2022, after receiving the necessary regulatory approvals. This acquisition expands Sartorius's portfolio with innovative chromatography systems, particularly for continuous manufacturing....more
Novasep Press Release (archived) / BioProcess International • January 6, 2021
Novasep announced a €6 million investment to build a new state-of-the-art viral vector fill & finish facility at its Seneffe site in Belgium. This expansion was aimed at meeting growing demand for gene therapies and viral vector-based vaccines....more
Novasep Press Release (archived) / CPHI Online • October 7, 2020
Novasep announced an investment of €6 million to upgrade its cGMP API manufacturing site in Mourenx, France. The investment was intended to enhance production capabilities for highly potent active pharmaceutical ingredients (HPAPIs) and advanced intermediates, strengthening its CDMO offering....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Novasep, are just a search away.